People · Operator
Named in public records as an officer, director or promoter · active 2025–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Strand Therapeutics Inc | — | Biotechnology | Series D+ | $166.1M | $883.9M | 2025 |
Samta Kundu at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Samta Kundu on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jory Bell | 1 | 4 |
| Jeb Keiper | 1 | 2 |
| Pegah Ebrahimi | 1 | 1 |
| Jacob Becraft | 1 | 1 |
| Samta Jacob Kundu | 1 | 1 |
| Tasuku Kitada | 1 | 1 |
| Ala Alenazi | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.